The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation of arsenic trioxide, for the treatment of acute promyelocytic leukemia (APL), an aggressive ...

Rifaximin SSD failed to significantly delay the onset of HE in patients with liver cirrhosis, but Bausch is yet to scrap the molecule’s development.

The protection of non-ferrous metals, particularly copper and its various alloys, remains a critical necessity in modern ...

The FDA has granted Priority Review to a supplemental biologics license application for Vyvgart, targeting broader use in myasthenia gravis. The review focuses on expanding Vyvgart’s label to reach a ...

The Sri Lanka Export Development Board (EDB), in collaboration with the Asian Development Bank (ADB) under the Policy-Based ...

The political report integrates three previously separate documents - the political report, the socio-economic report and the ...

From an animal perspective, elevated microbial pressure drives early microbiome evolution which is foundational to intestinal ...

The health ministry has amended the NDCT Rules to cut approval timelines for new drug trials and testing by half, aiming to ...

Vietnam’s development demands in the next phase require new approaches, new thinking and new action, Party General Secretary To Lam said at an international press conference announcing the results of ...

QTX-2101 is an investigational, oral arsenic trioxide therapy that has not yet been approved by any regulatory authority. Its safety and efficacy are currently under evaluation. This press release ...

Ahead of union budget 2026, a traditional dahi-cheeni ritual involving the president and finance minister has caught national ...

Eastern Refinery, established in 1968 under French contractor Technip, first planned a second unit in 2010. The government approved Tk13,000 crore in 2013, but no progress was made. In 2022, BPC ...